SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-002474
Filing Date
2018-02-20
Accepted
2018-02-20 16:14:04
Documents
72
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sbph-10k_20171231.htm 10-K 2846583
2 EX-23.1 sbph-ex231_6.htm EX-23.1 2730
3 EX-31.1 sbph-ex311_10.htm EX-31.1 20646
4 EX-31.2 sbph-ex312_11.htm EX-31.2 19639
5 EX-32.1 sbph-ex321_8.htm EX-32.1 9623
  Complete submission text file 0001564590-18-002474.txt   8748056

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbph-20171231.xml EX-101.INS 1790175
7 XBRL TAXONOMY EXTENSION SCHEMA sbph-20171231.xsd EX-101.SCH 53633
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20171231_cal.xml EX-101.CAL 55422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20171231_def.xml EX-101.DEF 202951
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20171231_lab.xml EX-101.LAB 449018
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20171231_pre.xml EX-101.PRE 356745
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37718 | Film No.: 18624732
SIC: 2834 Pharmaceutical Preparations